RETRACTED: BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma
- DOI
- 10.1016/j.bbrc.2017.07.139
- Published
- 2017-09
- Container
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbrc.2017.07.139,
title = {RETRACTED: BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma},
author = {Jin Li and Changgeng Qian and Qianqian Zhou and Jiwei Li and Kunlun Li and Pingyong Yi},
year = {2017},
journal = {Biochemical and Biophysical Research Communications},
doi = {10.1016/j.bbrc.2017.07.139},
url = {https://doi.org/10.1016/j.bbrc.2017.07.139}
}RIS
TY - JOUR TI - RETRACTED: BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma AU - Jin Li AU - Changgeng Qian AU - Qianqian Zhou AU - Jiwei Li AU - Kunlun Li AU - Pingyong Yi PY - 2017 JO - Biochemical and Biophysical Research Communications DO - 10.1016/j.bbrc.2017.07.139 UR - https://doi.org/10.1016/j.bbrc.2017.07.139 ER -
APA
Li, J., Qian, C., Zhou, Q., Li, J., Li, K., & Yi, P. (2017). RETRACTED: BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2017.07.139
Source records
- crossref · retrieved 2026-09-25T09:26:55.722Z